You will automatically be redirected in 10 seconds. Or, you can click the link below:

https://www.streetinsider.com/Corporate+News/Neurosense+Therapeutics+%28NRSN%29+Reports+Statistically+Significant+Clinical+Efficacy+in+Phase+2b+ALS+Trial/22527913.html